Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome

European Neurology
Y SekijimaN Yanagisawa

Abstract

We investigated the exact prevalence of dementia of Alzheimer type (DAT) and apolipoprotein E (ApoE) phenotypes in 106 Japanese Down's syndrome (DS) patients. Among these patients 16 were diagnosed as having DAT. The prevalence of DAT was 0% in the 30- to 39-year-old group, 16% in the 40- to 49-year-old group, and 38% in those over 50 years old. The frequency of the epsilon4 allele in DS patients with DAT was 18.8%, which was considerably higher than that of nondemented DS patients (4.5%) and Japanese nondemented controls (6.7%). Especially, the frequency of the epsilon4 allele in DS patients who developed DAT under 50 years was significantly higher (28.6%). DS patients certainly develop DAT at earlier ages but the prevalence of DAT in each group of patients was lower than previously recognized. It is very likely that the ApoE epsilon4 is a risk factor for DAT even in DS patients with a genetic predisposition to Alzheimer's disease.

Citations

Sep 12, 2006·Journal of Intellectual Disability Research : JIDR·A CoppusC van Duijin
Jul 5, 2005·Neurobiology of Aging·Bozena Mazur-KoleckaJanusz Frackowiak
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Monica MohanPeter K Carpenter
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Monica MohanPeter K Carpenter
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Monica MohanPeter K Carpenter
Jun 22, 2000·American Journal of Medical Genetics·S MoalemA C Warren
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Monica MohanCathy Bennett
Mar 27, 2001·Journal of Developmental and Behavioral Pediatrics : JDBP·G T Capone
May 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Nicole Schupf, Gertrude H Sergievsky
Jul 27, 2000·The British Journal of Psychiatry : the Journal of Mental Science·S DebM J Owen
Dec 19, 2014·EMBO Reports·Binbin LiuIrene Roberts
Mar 16, 2013·Psychiatric Genetics·Stefano VicariMarco Armando
Jan 3, 2020·International Journal of Geriatric Psychiatry·Shintaro TakenoshitaNorihito Yamada
Dec 10, 2008·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Ko-Suke NaitoShu-Ichi Ikeda
Apr 5, 2001·International Journal of Geriatric Psychiatry·M Simard, R van Reekum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.